» Articles » PMID: 24374826

Estrogen Receptor α in Cancer-associated Fibroblasts Suppresses Prostate Cancer Invasion Via Modulation of Thrombospondin 2 and Matrix Metalloproteinase 3

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2013 Dec 31
PMID 24374826
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The prostate cancer (PCa) microenvironment contains active stromal cells known as cancer-associated fibroblasts (CAF) that may play important roles in influencing tumor progression. Here we studied the role of CAF estrogen receptor alpha (ERα) and found that it could protect against PCa invasion. Immunohistochemistry on prostatectomy specimens showed that PCa patients with ERα-positive stroma had a significantly lower risk for biochemical recurrence. In vitro invasion assays further confirmed that the stromal ERα was able to reduce PCa cell invasion. Dissection of the molecular mechanism revealed that the CAF ERα could function through a CAF-epithelial interaction via selectively upregulating thrombospondin 2 (Thbs2) and downregulating matrix metalloproteinase 3 (MMP3) at the protein and messenger RNA levels. Chromatin immunoprecipitation assays further showed that ERα could bind to an estrogen response element on the promoter of Thbs2. Importantly, knockdown of Thbs2 led to increased MMP3 expression and interruption of the ERα mediated invasion suppression, providing further evidence of an ERα-Thbs2-MMP3 axis in CAF. In vivo studies using athymic nude mice injected with CWR22Rv1 (22Rv1) PCa epithelial cells and CAF cells ± ERα also confirmed that mice coimplanted with PCa cells and CAF ERα+ cells had less tumor foci in the pelvic lymph nodes, less metastases, and tumors showed less angiogenesis, MMP3, and MMP9 (an MMP3 downstream target) positive staining. Together, these data suggest that CAF ERα could play protective roles in suppressing PCa metastasis. Our results may lead to developing new and alternative therapeutic approaches to battle PCa via controlling ERα signaling in CAF.

Citing Articles

Disease specific urinary biomarkers in the central nervous system.

Duggins-Warf M, Ghalali A, Sesen J, Martinez T, Fehnel K, Pineda S Sci Rep. 2023; 13(1):19244.

PMID: 37935834 PMC: 10630515. DOI: 10.1038/s41598-023-46763-z.


Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.

Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N Mol Cancer. 2023; 22(1):159.

PMID: 37784082 PMC: 10544417. DOI: 10.1186/s12943-023-01860-5.


Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.

Belluti S, Imbriano C, Casarini L Cancers (Basel). 2023; 15(18).

PMID: 37760622 PMC: 10526871. DOI: 10.3390/cancers15184653.


Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients.

Zhang R, Liu F J Transl Med. 2022; 20(1):453.

PMID: 36195908 PMC: 9533530. DOI: 10.1186/s12967-022-03656-5.


Sex-specific multi-level 3D genome dynamics in the mouse brain.

Rocks D, Shukla M, Ouldibbat L, Finnemann S, Kalluchi A, Rowley M Nat Commun. 2022; 13(1):3438.

PMID: 35705546 PMC: 9200740. DOI: 10.1038/s41467-022-30961-w.


References
1.
Liotta L, Kohn E . The microenvironment of the tumour-host interface. Nature. 2001; 411(6835):375-9. DOI: 10.1038/35077241. View

2.
Streit M, Riccardi L, Velasco P, Brown L, Hawighorst T, Bornstein P . Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A. 1999; 96(26):14888-93. PMC: 24743. DOI: 10.1073/pnas.96.26.14888. View

3.
Grubisha M, Cifuentes M, Hammes S, DeFranco D . A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility. Mol Endocrinol. 2012; 26(6):940-54. PMC: 3355541. DOI: 10.1210/me.2011-1371. View

4.
Bergeron J, Crews D, McLachlan J . PCBs as environmental estrogens: turtle sex determination as a biomarker of environmental contamination. Environ Health Perspect. 1994; 102(9):780-1. PMC: 1567153. DOI: 10.1289/ehp.94102780. View

5.
Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G . Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem. 2000; 275(8):5379-87. DOI: 10.1074/jbc.275.8.5379. View